FENNEC PHARMACEUTICALS INC. Shareholders' Equity
FENNEC PHARMACEUTICALS INC. (FENC) had Shareholders' Equity of $42.44 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $42.44M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $37.67M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $35.47M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$4.49M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $42.44M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $37.67M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $35.47M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$4.49M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$7.46M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$5.88M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$5.87M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$5.17M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.36M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $3.01M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | -$11.62M 10-K · filed 2026-03-27 | |
| 2023-09-30 | -$10.53M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | -$9.73M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | -$7.34M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | -$2.57M 10-K · filed 2025-03-26 | |
| 2022-09-30 | $2.80M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $8.54M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $12.52M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $15.77M 10-K · filed 2024-03-29 | |
| 2021-09-30 | $19.01M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $22.28M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $24.93M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $29.07M 10-K · filed 2023-03-29 | |
| 2020-09-30 | $31.18M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $36.13M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $8.46M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $11.88M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $15.00M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $16.48M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $19.21M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $21.31M 10-K · filed 2021-03-30 | |
| 2018-09-30 | $22.86M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $24.86M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $25.66M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $26.76M 10-K · filed 2020-02-14 | |
| 2017-09-30 | $8.86M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $9.68M 10-Q · filed 2017-11-13 | |
| 2017-03-31 | $2.86M 10-Q · filed 2017-11-13 | |
| 2016-12-31 | $3.57M 10-K · filed 2019-03-15 | |
| 2016-09-30 | $4.22M 10-Q · filed 2017-05-12 | |
| 2016-06-30 | $4.65M 10-Q · filed 2017-05-12 | |
| 2016-03-31 | $243.00K 10-Q · filed 2017-05-12 | |
| 2015-12-31 | $548.00K 10-K · filed 2018-03-28 | |
| 2015-09-30 | $1.02M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $1.11M 10-Q · filed 2016-11-14 | |
| 2015-03-31 | $826.00K 10-Q · filed 2016-11-14 | |
| 2014-12-31 | $613.00K 10-K · filed 2017-03-29 | |
| 2014-09-30 | -$3.23M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$4.66M 10-Q · filed 2014-11-13 | |
| 2014-03-31 | -$4.33M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | -$1.46M 10-K · filed 2016-03-28 | |
| 2013-09-30 | -$4.13M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | -$2.43M 10-Q · filed 2013-11-18 | |
| 2013-03-31 | -$9.06M 10-Q · filed 2013-11-18 | |
| 2012-12-31 | -$4.96M 10-Q · filed 2015-11-12 | |
| 2012-09-30 | $1.28M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.04M 10-Q · filed 2012-11-14 | |
| 2012-03-31 | $2.60M 10-Q · filed 2012-11-14 | |
| 2011-12-31 | -$120.00K 10-Q · filed 2014-11-13 | |
| 2011-09-30 | -$3.67M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$684.00K 10-Q · filed 2011-11-14 | |
| 2011-03-31 | -$283.00K 10-Q · filed 2011-11-14 | |
| 2010-12-31 | -$4.93M 10-Q · filed 2014-11-13 | -$4.92M 10-Q · filed 2011-08-15 |
| 2009-12-31 | $406.00K 10-Q · filed 2014-11-13 | $407.00K 10-Q · filed 2011-08-15 |
| 2008-12-31 | $3.05M 10-Q · filed 2014-11-13 | |
| 2007-12-31 | $14.15M 10-Q · filed 2014-11-13 | |
| 2006-12-31 | $1.27M 10-Q · filed 2014-11-13 | |
| 2005-12-31 | $11.08M 10-Q · filed 2014-11-13 | |
| 2004-12-31 | $16.65M 10-Q · filed 2014-11-13 | |
| 2004-06-30 | $20.45M 10-Q · filed 2014-11-13 | |
| 2003-06-30 | $698.00K 10-Q · filed 2014-11-13 | |
| 2002-06-30 | $6.07M 10-Q · filed 2014-11-13 | |
| 2001-06-30 | $9.79M 10-Q · filed 2014-11-13 | |
| 2000-06-30 | $47.00K 10-Q · filed 2014-11-13 | |
| 1999-06-30 | $242.00K 10-Q · filed 2014-11-13 | |
| 1998-06-30 | -$435.00K 10-Q · filed 2014-11-13 | |
| 1997-06-30 | -$37.00K 10-Q · filed 2014-11-13 | |
| 1997-06-23 | -$37.00K 10-K · filed 2013-04-01 | |
| 1996-09-02 | $0.00 10-Q · filed 2014-11-13 | |
| 1996-06-30 | $0.00 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |